AzTrials
AzTrials

Brain InjuryTCS8NCT02050633

PariS -TBI Study: Paris Severe Traumatic Brain Injury Study - 8 Years

An observational study of Brain Injury and Craniocerebral Trauma, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of the protocol is to pursue the long-term follow-up of a large cohort of severe traumatic brain injury patients. This outcome is to be described in terms of activity, participation, quality of life, socio-professional outcome, economical consequences and impact on caregivers, and in relation to health… Read more about this study

Who is it for?
Ages 15 years and older
How many people
130 participants
Where
1 siteFrance
Study dates
Dec 2014to Apr 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients had severe TC in the Parisian area between 2005 and 2008 and were evaluated 4 years.

Who may be able to join

None listed.

Who cannot join

  • Refusal to participate
  • Impossibility to contact the person
  • Current living place outside the Parisian area
  • Impossibility to answer the questionnaire, in the absence of a proxy to assist

Trial locations and contacts

1 site in 1 country.

France1 site
  • CRFTC

    Paris, 75014

Other trials in France

About this study

Official title: Eight-year Outcome and Health Care After Severe Traumatic Brain Injury in the Parisian Area

The objective of the protocol is to pursue the long-term follow-up of a large cohort of severe traumatic brain injury patients. This outcome is to be described in terms of activity, participation, quality of life, socio-professional outcome, economical consequences and impact on caregivers, and in relation to health care provision.

Secondary objectives are to measure the impact on outcome of several predictive factors; to evaluate evolution of patients since the last (four-year) evaluation.

Read the detailed description

This work represents a part of a larger collaborative prospective study called PariS-TBI (Severe Traumatic Brain Injury in the Parisian area) financed by the French National Authority for Health. The Paris-TBI study was undertaken in 2004, to provide epidemiological data. Patients aged 15 or more were included if they had sustained a severe TBI in the Parisian area during a 20-months period (2005-2007), defined by an initial Coma Glasgow Score (GCS) of 8 or less. Data from patients' demographics, injury characteristics, acute and post acute phase were collected prospectively. A total of 504 patients were included, of which 257 were alive at the time of this study. Patients (n = 134) were evaluated through a phone interview at one year post traumatism, and had a face-to-face evaluation at four years post-injury (n = 147).

Investigations of the present work will be undertaken at eight years after the injury. Patients of the initial cohort will be contacted through post and phone call. Information about this follow up study will be given orally and through written form. Informed consent of patient or legal advisor will be obtained before setting an appointment for the evaluation.

Evaluation will take place either in the patient's place of living, or in a clinical setting in the hospitals Broussais, Paris, France or Raymond Poincaré, Garches, France, according to the patient's choice.

A trained neuropsychologist will lead the evaluations, during an interview with the patient and the informal caregiver, defined as the person (family member or friend), most responsible for day-to-day decision making and care for the patient. If a patient cannot attend the interview, a short questionnaire will be proposed to him by the neuropsychologist by phone.

Demographic and pre-traumatism clinical data will be available from the initial study, as well as data on type and severity of traumatism, and on evolution during acute care. Data from the one-year and the four-year assessments will be available.

Data assessed through the present study will include an evaluation of deficiencies: presence of somatic deficiencies, mood difficulties (Hospital Anxiety and Depression Score), cognitive deficiencies (Dysexecutive Questionnaire, questionnaire of complaints, filled in both by the patient himself and by his proxy). Neuropsychological testing will include the California Verbal Learning Test, Trail Making Test, the WAIS-IV Processing Speed Index, and the 6-Elements Test.

Activities will be evaluated by the Glasgow Outcome Scale-Extended, and specifically through questions addressing driving ability, and ability to perform instrumental activities.

Professional activity and change, and quality of life at work will be assessed through a standardized questionnaire.

Data on patients' clinical care and services will be collected, including medical care, therapies, home assistance, socio-vocational assistance. Unmet need of services and barriers to care access will be assessed through a standardized questionnaire.

Data on the quality of life of the informal caregiver and an evaluation of the burden of care will be collected, using the ZARIT questionnaire. Data on economical consequences of the injury on the patient, and on his care provider will be collected.

The exploitation of this large database will enable an up-to-date description of the long term outcomes of severe TBI patients in the Parisian area. It will be used to clarify the role of several factors on long term activities and participations and on informal care burden.

The comparison with the previous evaluations will allow evaluation of late evolution and of its determinants.

Keywords
Craniocerebral Trauma, Long term outcome, Activities of Daily Living, Cognitive Deficiency, Health Care Quality, Access, and Evaluation, Burden of care
Medical subject headings
Brain Injuries, Craniocerebral Trauma, Trauma, Nervous System

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02050633
Study groupRoleWhat they receive
Severe cranial traumaThis is a cohort of adult patients who have suffered a severe TBI between 1 July 2005 and 1 May 2007.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glasgow Outcome Scale-Extended

    This scale is assessed by a structured interview about the difficulties the patient in simple or elaborate acts of daily life

    Measured: Eight years post-injury (one unique all-including evaluation)

Secondary outcomes (8)
  1. Neuropsychological testing: memory (California Verbal Learning Test), executive functioning (6-Elements Test, Dysexecutive Questionnaire by patient and caregiver), speed index (Trail Making Test, WAIS-IV Processing Speed Index).

    Measured: Eight years post-injury (one unique all-including evaluation)

  2. TBI-related complaints, by patient and caregiver

    Measured: Eight years post-injury (one unique all-including evaluation)

  3. Capacity of motor vehicle driving, independence in daily living activities

    Measured: Eight years post-injury (one unique all-including evaluation)

  4. Socio-professional integration

    Measured: Eight years post-injury (one unique all-including evaluation)

  5. Hospital Anxiety and Depression

    Measured: Eight years post-injury (one unique all-including evaluation)

  6. Patient's quality of life (0-10 numeric scale, by patient and caregiver)

    Measured: Eight years post-injury (one unique all-including evaluation)

  7. Quality of life of caregiver

    Measured: Eight years post-injury (one unique all-including evaluation)

  8. Caregiver burden (ZARIT questionnaire)

    Measured: Eight years post-injury (one unique all-including evaluation)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2014 (estimated)
  2. Study startDec 2014
  3. Primary completionDec 2017 (estimated)
  4. Study completionApr 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02050633
Sponsor's protocol ID
2013-A00881-44
Acronym
TCS8
Status last verified
Nov 2017
First submitted
29 Jan 2014
Last updated
20 Nov 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injury and Craniocerebral Trauma, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glasgow Outcome Scale-Extended (time frame: Eight years post-injury (one unique all-including evaluation)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in